Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-β1 on collagenase expression in dermal fibroblasts

Wound Repair and Regeneration

Volumn 15, Issue 2, 2007, Pages 236-244

  Kilani, Ruhangiz T ^a   Guilbert, Larry ^a   Lin, Xiaoyue ^a   Ghahary, Aziz ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; MESSENGER RNA; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

14-3-3 PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; COLLAGENASES; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLASTS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MALE; MATRIX METALLOPROTEINASE 1; SKIN; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 33847723457     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2007.00210.x     Document Type: Article

References (42)

1. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999; 274: 21494-4.
2. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA. Crit Rev Oral Biol Med 1993; 4: 197-250.
3. Ghahary A, Shen YJ, Nedelec B, Wang R, Scott PG, Tredget EE. Collangenase production is lower in post-burn hypertrophic scar fibroblasts than normal fibroblasts and is down regulated by insulin-like growth factor-1. J Invest Dermatol 1996; 106: 476-87.
4. Martens GJ, Piosik PA, Danen EH. Biochem Biophys Res Commun 1992; 184: 1456-9.
5. Moore BE, Perez VJ. Specific acidic proteino of the nervous system. In: Carlson FD, editor. Physiological and biochemical aspects of nervous integration. Englewood Cliffs, NJ: Prentice-Hall, 1967: 343-59.
6. 2+, calmodulin-dependent protein kinase II. FEBS Lett 1987; 219: 79-82.
7. Ichimura T, Isobe T, Okuyama T, Takahashi N, Araki K, Kuwano R, Takahashi Y. Molecular cloning of cDNA coding for brain specific 14-3-3 protein, a protein kinase-dependent activator of tyrosine and tryptophan hydroxylases. Proc Natl Acad Sci USA 1988; 85: 7084-8.
8. Toker AEC, Sellers LA, Aitken A. Protein kinase C inhibitor proteins. Purification from sheep brain and sequence similarity to lipocortins and 14-3-3 protein. Eur J Biochem 1990; 191: 421-9.
9. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thaiagalingam S, Kinzler KW, Volgelstein B. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3-11.
10. Craparo AFR, Gustafson TA. 14-3-3 (epsilon) interacts with the insulin-like growth factor I receptor and insulin receptor substrate I in a phosphoserine dependent manner. J Biol Chem 1997; 272: 11663-9.
11. Chan TA, Hwang PM, Hermeking H, Kinzler KW, Vogelstein B. Cooperative effects of genes controlling the G(2)/M checkpoint. Genes Dev 2000; 14: 1584-8.
12. Laronga CYH, Neal C, Lee MH. Association of the cyclic-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 2000; 275: 23106-12.
13. Yaffe M. How do 14-3-3 proteins work? Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 2002; 513: 53-7.
14. Chan TAHH, Lengauer C, Kinzler KW, Vogelstein B. 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616-20.
15. Roberts AB, Sporn MB. In: Sporn MB, Roberts AB, editor Peptide growth factors and their receptors. Springer Verlag, 1990: 421-72.
16. Hill CS, Treisman R. Transcriptional regulation by extracellular signals. Mechanisms and specificity. Cell 1995; 80: 199-211.
17. Goldstein RH, Folkis CF, Polch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989; 124: 964-70.
18. Ignotz RA, Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337-45.
19. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105: 1039-45.
20. Allen JB, Wong HL, Guyre P, Simon GL, Bienkowski MJ, Wahl SM. Suppression of monocyte function and differential regulation of IL-1 and IL-4 contribute to resolution of experimental arthritis. J Immunol 1993; 151: 4344-51.
21. Overall CM, Wrana JL Sodek. Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta. J Biol Chem 1989; 264: 1860-9.
22. Edwards DR, Murphy G, Reynolds JJ, Whitman SE, Docherty AJP, Angel P, Heath JK. Transforming growth factor-beta stimulates the expression of collagenase and metalloproteinase inhibitor. EMBO J 1987; 6: 1899-1904.
23. Edwall D, Schalling M, Jennische E, Norstedt G. Induction of insulin-like growth factor-1 messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology 1989; 124: 820-5.
24. Blatti SP, Foster DN, Ranganthan G, Moses HL, Getz MJ. Induction of fibronectin gene transcription and mRNA is a primary response to growth-factor stimulation of AKR-2B cells. Proc Natl Acad Sci USA 1988; 85: 1119-1254.
25. Steenfos HH, Jansson JO. Gene expression of insulin-like growth factor-1 and IGF-1 receptor during wound healing in rats. Eur J Surg 1992; 158: 327-31.
26. Hansson HA, Jennische E, Skottner A. Regenerating endothelial cells express insulin-like growth factor-1 immunoactivity after arterial injury. Cell Tissue Res 1987; 250: 499-505.
27. Ghahary Shen YJ, Nedlec B, Scott PG, Tredget EE. Enhance expression of mRNA for insulin-like growth factor-1 in post burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts. Mol Cell Biochem 1995; 148: 25-32.
28. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. New Engl J Med 1994; 331: 1286-92.
29. Satoh JKK, Kurohara K, Yukitake M, Kuroda Y. The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol 1999; 41: 216-25.
30. Boston PFJP, Thompson RJ. Human 14-3-3 protein: radio-immunoassay, tissue distribution and cerebrospinal fluid levels in patients with neurological disorders. J Neurochem 1982; 38: 1475-82.
31. Ghahary A, Karimi BF, Marcoux Y, Li Y, Tredget EE, Kilani RT, Li L, Zheng J, Karami , Keller B, Weinfeld M. Keratinocyte releasable 14-3-3 protein functions as a potent collagenase stimulating factor in fibroblasts. J Invest Dermatol 2004; 122: 1188-97.
32. Karimi-Busheri F, Marcoux Y, Tredget EE, Li L, Zhing J, Ghorashi M, Weinfeld M, Ghahary A. Expression of a releasable form of annexin II by human keratinocytes. J Cell Biochem 2002; 86: 737-47.
33. Rheinwald JG, Green H. 1975 Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 1975; 6: 331-43.
34. Ghahary A, Tredget EE, Chang LJ, Scott PG, Shen Q. Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta 1. J Invest Dermatol 1998; 110: 800-5.
35. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. Differentiated keratinocyte-releasable stratifin (14-3-3 sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005; 124: 170-7.
36. Maas-Szabowski N, Stark HJ, Fusenig NE. Keratinocyte growth regulation in defined organotypic cultures through IL-1 induced keratinocyte growth factor expression in resting fibroblasts. J Invest Dermatol 2000; 114: 1075-84.
37. Grone A. Keratinocytes and cytokines. Vet Immunol Immunopathol 2002; 88: 1-12.
38. Bahar MA, Bauer B, Tredget EE, Ghahary A. Dermal fibroblasts from different layers of human skin are heteregenous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 2004; 12: 175-82.
39. Bird JLE, Tyler JA. Dexamethasone potentiates the stimulatory effect of insulin-like growth factor-I on collagen production in cultured human fibroblasts. J Endocrinol 1994; 142: 571-9.
40. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor β causes a persistent increase in steady state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987; 247: 597-604.
41. Ghahary A, Marcoux Y, Karimi-Busheri F, Tredget EE. Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta 1. J Cell Biochem 2001; 83: 239-48.
42. Schoop VM, Mirancea N, Fusening N. Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. J Invest Dermatol 1999; 112: 343-53.